8 Billion Secret
- All
- News
-
Indictment Details Former Samsung Executive's Plan to Steal Company Secrets for Foxconn China Chip Factory
When former Samsung executive Choi Jinseog won a contract with Taiwan's Foxconn in 2018, he tapped his former employer's supplier network to steal secrets to help his new client set up a chip factory in China, an indictment by South Korean prosecutors alleges.
-
FTX Crypto Collapse: At Least $1 Billion Client Fund Said to Be Missing
At least $1 billion (nearly Rs. 8,050 crore) of customer funds have vanished from collapsed crypto exchange FTX, according to two people familiar with the matter. The exchange's founder Sam Bankman-Fried secretly transferred $10 billion (nearly Rs. 80,500 crore) of customer funds from FTX to Bankman-Fried's trading company Alameda Research, the peo...
-
Can A Bunch Of Doctors Keep An $8 Billion Secret? Not On Twitter
In New Orleans Monday, a major medical organization attempted a feat perhaps as hard as treating the disease doctors were there to discuss. They asked a packed convention hall of attendees not to tweet the confidential, market-moving data they had flown in to see.
-
Indictment Details Former Samsung Executive's Plan to Steal Company Secrets for Foxconn China Chip Factory
When former Samsung executive Choi Jinseog won a contract with Taiwan's Foxconn in 2018, he tapped his former employer's supplier network to steal secrets to help his new client set up a chip factory in China, an indictment by South Korean prosecutors alleges.
-
FTX Crypto Collapse: At Least $1 Billion Client Fund Said to Be Missing
At least $1 billion (nearly Rs. 8,050 crore) of customer funds have vanished from collapsed crypto exchange FTX, according to two people familiar with the matter. The exchange's founder Sam Bankman-Fried secretly transferred $10 billion (nearly Rs. 80,500 crore) of customer funds from FTX to Bankman-Fried's trading company Alameda Research, the peo...
-
Can A Bunch Of Doctors Keep An $8 Billion Secret? Not On Twitter
In New Orleans Monday, a major medical organization attempted a feat perhaps as hard as treating the disease doctors were there to discuss. They asked a packed convention hall of attendees not to tweet the confidential, market-moving data they had flown in to see.
